TCL Archive ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children January 30, 2004
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005